Progyny Inc (PGNY)

Return on total capital

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Earnings before interest and tax (EBIT) (ttm) US$ in thousands 62,184 51,690 44,756 38,410 23,341 19,847 17,657 20,475 32,340 33,689 29,452 16,724 8,348 8,331 6,572
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 553,429 515,393 469,499 424,401 376,968 346,856 311,024 279,619 251,822 224,113 204,541 184,618 166,947 125,886 118,710 119,492 114,271 -91,250
Return on total capital 11.24% 10.03% 9.53% 9.05% 6.19% 5.72% 5.68% 7.32% 12.84% 15.03% 14.40% 9.06% 5.00% 6.62% 5.54%

December 31, 2023 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $62,184K ÷ ($—K + $553,429K)
= 11.24%

Progyny Inc's return on total capital has shown a positive trend over the past eight quarters. The company's return on total capital has been gradually increasing from 5.68% in Q2 2022 to 11.24% in Q4 2023. This indicates that Progyny Inc has been more efficient in generating profits from the total capital employed in its operations.

The consistent improvement in the return on total capital signifies that Progyny Inc has been effectively utilizing its capital resources to generate higher returns for its stakeholders. This trend reflects positively on the company's operational efficiency and management's ability to generate value from its assets and investments.

Overall, the increasing trend in return on total capital demonstrates Progyny Inc's ability to generate satisfactory returns on the total capital employed in its business operations.


Peer comparison

Dec 31, 2023

Company name
Symbol
Return on total capital
Progyny Inc
PGNY
11.24%
DaVita HealthCare Partners Inc
DVA
151.76%
Sotera Health Co
SHC
10.37%